Clinical trial
A Safety and Efficacy Study of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye Disease
NCT02665234 is registered in ClinicalTrials.gov with Mimetogen Pharmaceuticals USA, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Safety and Efficacy Study of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye Disease
- Lead sponsor
- Mimetogen Pharmaceuticals USA, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2016
- Completion date
- March 31, 2017
- Enrollment
- 400 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.